APO Research
Talk to an analyst

APO RESEARCH · REPORT

API Contract Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global API Contract Manufacturing Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchAPI Contract Manufacturing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal API Contract Manufacturing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal API Contract Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal API Contract Manufacturing Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal API Contract Manufacturing Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global API Contract Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for API Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for API Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for API Contract Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the API Contract Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the API Contract Manufacturing market include Teva Pharmaceuticals Industries Ltd, Sun Pharmaceutical Industries Ltd, Novartis AG, Merck＆Co.，Inc, GlaxoSmithKline Pharmaceuticals Ltd, AstraZeneca Plc, Sandoz-Lek-Biochemie, Reddy's Laboratories Ltd and Ranbaxy Laboratories Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global API Contract Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of API Contract Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents API Contract Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global API Contract Manufacturing market.

API Contract Manufacturing Segment by Company

Teva Pharmaceuticals Industries Ltd

Sun Pharmaceutical Industries Ltd

Novartis AG

Merck＆Co.，Inc

GlaxoSmithKline Pharmaceuticals Ltd

AstraZeneca Plc

Sandoz-Lek-Biochemie

Reddy's Laboratories Ltd

Ranbaxy Laboratories Ltd.

Piramal Pharma Solutions

BoehringerIngelhein GmbH

API Contract Manufacturing Segment by Type

Commercial Manufacturing

Clinical Manufacturing

API Contract Manufacturing Segment by Application

Oncology

Central nervous system

Cardiovascular disorder

Gastrointestinal disorders

Genitourinary disorders

Musculoskeletal disorders

Pulmonary disorders

Metabolic disorder

Infectious diseases

API Contract Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global API Contract Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the API Contract Manufacturing key companies, revenue, market share, and recent developments.

3. To split the API Contract Manufacturing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions API Contract Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify API Contract Manufacturing significant trends, drivers, influence factors in global and regions.

6. To analyze API Contract Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global API Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of API Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of API Contract Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global API Contract Manufacturing industry.

Chapter 3: Detailed analysis of API Contract Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of API Contract Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of API Contract Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. API Contract Manufacturing Industry Trends Table 2. API Contract Manufacturing Industry Drivers Table 3. API Contract Manufacturing Industry Opportunities and Challenges Table 4. API Contract Manufacturing Industry Restraints Table 5. Global API Contract Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global API Contract Manufacturing Revenue Share by Company (2021-2026) Table 7. Global API Contract Manufacturing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global API Contract Manufacturing Key Company Manufacturing Base & Headquarters Table 9. Global API Contract Manufacturing Company, Product Type & Application Table 10. Global API Contract Manufacturing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global API Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Commercial Manufacturing Table 15. Significant Companies of Clinical Manufacturing Table 16. Global API Contract Manufacturing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global API Contract Manufacturing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global API Contract Manufacturing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global API Contract Manufacturing Sales Value Share by Type (2021-2026) Table 20. Global API Contract Manufacturing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Oncology Table 22. Significant Companies of Central nervous system Table 23. Significant Companies of Cardiovascular disorder Table 24. Significant Companies of Gastrointestinal disorders Table 25. Significant Companies of Genitourinary disorders Table 26. Significant Companies of Musculoskeletal disorders Table 27. Significant Companies of Pulmonary disorders Table 28. Significant Companies of Metabolic disorder Table 29. Significant Companies of Infectious diseases Table 30. Global API Contract Manufacturing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global API Contract Manufacturing Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global API Contract Manufacturing Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global API Contract Manufacturing Sales Value Share by Application (2021-2026) Table 34. Global API Contract Manufacturing Sales Value Share by Application (2027-2032) Table 35. Global API Contract Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global API Contract Manufacturing Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global API Contract Manufacturing Sales Value Share by Region (2021-2026) Table 38. Global API Contract Manufacturing Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global API Contract Manufacturing Sales Value Share by Region (2027-2032) Table 40. Global API Contract Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global API Contract Manufacturing Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global API Contract Manufacturing Sales Value Market Share by Country (2021-2026) Table 43. Global API Contract Manufacturing Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global API Contract Manufacturing Sales Value Market Share by Country (2027-2032) Table 45. Teva Pharmaceuticals Industries Ltd Company Information Table 46. Teva Pharmaceuticals Industries Ltd Business Overview Table 47. Teva Pharmaceuticals Industries Ltd API Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Teva Pharmaceuticals Industries Ltd API Contract Manufacturing Product Portfolio Table 49. Teva Pharmaceuticals Industries Ltd Recent Development Table 50. Sun Pharmaceutical Industries Ltd Company Information Table 51. Sun Pharmaceutical Industries Ltd Business Overview Table 52. Sun Pharmaceutical Industries Ltd API Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Sun Pharmaceutical Industries Ltd API Contract Manufacturing Product Portfolio Table 54. Sun Pharmaceutical Industries Ltd Recent Development Table 55. Novartis AG Company Information Table 56. Novartis AG Business Overview Table 57. Novartis AG API Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Novartis AG API Contract Manufacturing Product Portfolio Table 59. Novartis AG Recent Development Table 60. Merck＆Co.，Inc Company Information Table 61. Merck＆Co.，Inc Business Overview Table 62. Merck＆Co.，Inc API Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Merck＆Co.，Inc API Contract Manufacturing Product Portfolio Table 64. Merck＆Co.，Inc Recent Development Table 65. GlaxoSmithKline Pharmaceuticals Ltd Company Information Table 66. GlaxoSmithKline Pharmaceuticals Ltd Business Overview Table 67. GlaxoSmithKline Pharmaceuticals Ltd API Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. GlaxoSmithKline Pharmaceuticals Ltd API Contract Manufacturing Product Portfolio Table 69. GlaxoSmithKline Pharmaceuticals Ltd Recent Development Table 70. AstraZeneca Plc Company Information Table 71. AstraZeneca Plc Business Overview Table 72. AstraZeneca Plc API Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. AstraZeneca Plc API Contract Manufacturing Product Portfolio Table 74. AstraZeneca Plc Recent Development Table 75. Sandoz-Lek-Biochemie Company Information Table 76. Sandoz-Lek-Biochemie Business Overview Table 77. Sandoz-Lek-Biochemie API Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sandoz-Lek-Biochemie API Contract Manufacturing Product Portfolio Table 79. Sandoz-Lek-Biochemie Recent Development Table 80. Reddy's Laboratories Ltd Company Information Table 81. Reddy's Laboratories Ltd Business Overview Table 82. Reddy's Laboratories Ltd API Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Reddy's Laboratories Ltd API Contract Manufacturing Product Portfolio Table 84. Reddy's Laboratories Ltd Recent Development Table 85. Ranbaxy Laboratories Ltd. Company Information Table 86. Ranbaxy Laboratories Ltd. Business Overview Table 87. Ranbaxy Laboratories Ltd. API Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Ranbaxy Laboratories Ltd. API Contract Manufacturing Product Portfolio Table 89. Ranbaxy Laboratories Ltd. Recent Development Table 90. Piramal Pharma Solutions Company Information Table 91. Piramal Pharma Solutions Business Overview Table 92. Piramal Pharma Solutions API Contract Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Piramal Pharma Solutions API Contract Manufacturing Product Portfolio Table 94. Piramal Pharma Solutions Recent Development Table 95. BoehringerIngelhein GmbH Company Information Table 96. BoehringerIngelhein GmbH Business Overview Table 97. BoehringerIngelhein GmbH API Contract Manufacturing Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. BoehringerIngelhein GmbH API Contract Manufacturing Product Portfolio Table 99. BoehringerIngelhein GmbH Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. API Contract Manufacturing Product Image Figure 2. Global API Contract Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global API Contract Manufacturing Market Size (2021-2032) & (US$ Million) Figure 4. Global API Contract Manufacturing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Commercial Manufacturing Image Figure 8. Clinical Manufacturing Image Figure 9. Global API Contract Manufacturing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global API Contract Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global API Contract Manufacturing Sales Value Share by Type (2021-2032) Figure 12. Oncology Image Figure 13. Central nervous system Image Figure 14. Cardiovascular disorder Image Figure 15. Gastrointestinal disorders Image Figure 16. Genitourinary disorders Image Figure 17. Musculoskeletal disorders Image Figure 18. Pulmonary disorders Image Figure 19. Metabolic disorder Image Figure 20. Infectious diseases Image Figure 21. Global API Contract Manufacturing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global API Contract Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global API Contract Manufacturing Sales Value Share by Application (2021-2032) Figure 24. Global API Contract Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global API Contract Manufacturing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America API Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 27. North America API Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe API Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 29. Europe API Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific API Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific API Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America API Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 33. South America API Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa API Contract Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa API Contract Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt API Contract Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Commercial Manufacturing
  • Clinical Manufacturing
Applications
  • Oncology
  • Central nervous system
  • Cardiovascular disorder
  • Gastrointestinal disorders
  • Genitourinary disorders
  • Musculoskeletal disorders
  • Pulmonary disorders
  • Metabolic disorder
  • Infectious diseases
Companies covered
  • Teva Pharmaceuticals Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Merck＆Co.，Inc
  • GlaxoSmithKline Pharmaceuticals Ltd
  • AstraZeneca Plc
  • Sandoz-Lek-Biochemie
  • Reddy's Laboratories Ltd
  • Ranbaxy Laboratories Ltd.
  • Piramal Pharma Solutions
  • BoehringerIngelhein GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global API Contract Manufacturing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global API Contract Manufacturing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 API Contract Manufacturing Market Dynamics
  1. 2.1 API Contract Manufacturing Industry Trends
  2. 2.2 API Contract Manufacturing Industry Drivers
  3. 2.3 API Contract Manufacturing Industry Opportunities and Challenges
  4. 2.4 API Contract Manufacturing Industry Restraints
3 API Contract Manufacturing Market by Company
  1. 3.1 Global API Contract Manufacturing Company Revenue Ranking in 2025
  2. 3.2 Global API Contract Manufacturing Revenue by Company (2021-2026)
  3. 3.3 Global API Contract Manufacturing Company Ranking (2024-2026)
  4. 3.4 Global API Contract Manufacturing Company Manufacturing Base and Headquarters
  5. 3.5 Global API Contract Manufacturing Company Product Type and Application
  6. 3.6 Global API Contract Manufacturing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global API Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 API Contract Manufacturing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 API Contract Manufacturing Market by Type
  1. 4.1 API Contract Manufacturing Type Introduction
  2. 4.1.1 Commercial Manufacturing
  3. 4.1.2 Clinical Manufacturing
  4. 4.2 Global API Contract Manufacturing Sales Value by Type
  5. 4.2.1 Global API Contract Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global API Contract Manufacturing Sales Value by Type (2021-2032)
  7. 4.2.3 Global API Contract Manufacturing Sales Value Share by Type (2021-2032)
5 API Contract Manufacturing Market by Application
  1. 5.1 API Contract Manufacturing Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Central nervous system
  4. 5.1.3 Cardiovascular disorder
  5. 5.1.4 Gastrointestinal disorders
  6. 5.1.5 Genitourinary disorders
  7. 5.1.6 Musculoskeletal disorders
  8. 5.1.7 Pulmonary disorders
  9. 5.1.8 Metabolic disorder
  10. 5.1.9 Infectious diseases
  11. 5.2 Global API Contract Manufacturing Sales Value by Application
  12. 5.2.1 Global API Contract Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.2.2 Global API Contract Manufacturing Sales Value by Application (2021-2032)
  14. 5.2.3 Global API Contract Manufacturing Sales Value Share by Application (2021-2032)
6 API Contract Manufacturing Regional Value Analysis
  1. 6.1 Global API Contract Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global API Contract Manufacturing Sales Value by Region (2021-2032)
  3. 6.2.1 Global API Contract Manufacturing Sales Value by Region: 2021-2026
  4. 6.2.2 Global API Contract Manufacturing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America API Contract Manufacturing Sales Value (2021-2032)
  7. 6.3.2 North America API Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe API Contract Manufacturing Sales Value (2021-2032)
  10. 6.4.2 Europe API Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific API Contract Manufacturing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific API Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America API Contract Manufacturing Sales Value (2021-2032)
  16. 6.6.2 South America API Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa API Contract Manufacturing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa API Contract Manufacturing Sales Value Share by Country, 2025 VS 2032
7 API Contract Manufacturing Country-level Value Analysis
  1. 7.1 Global API Contract Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global API Contract Manufacturing Sales Value by Country (2021-2032)
  3. 7.2.1 Global API Contract Manufacturing Sales Value by Country (2021-2026)
  4. 7.2.2 Global API Contract Manufacturing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt API Contract Manufacturing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt API Contract Manufacturing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt API Contract Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals Industries Ltd
  2. 8.1.1 Teva Pharmaceuticals Industries Ltd Company Information
  3. 8.1.2 Teva Pharmaceuticals Industries Ltd Business Overview
  4. 8.1.3 Teva Pharmaceuticals Industries Ltd API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Industries Ltd API Contract Manufacturing Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Industries Ltd Recent Developments
  7. 8.2 Sun Pharmaceutical Industries Ltd
  8. 8.2.1 Sun Pharmaceutical Industries Ltd Company Information
  9. 8.2.2 Sun Pharmaceutical Industries Ltd Business Overview
  10. 8.2.3 Sun Pharmaceutical Industries Ltd API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Industries Ltd API Contract Manufacturing Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Industries Ltd Recent Developments
  13. 8.3 Novartis AG
  14. 8.3.1 Novartis AG Company Information
  15. 8.3.2 Novartis AG Business Overview
  16. 8.3.3 Novartis AG API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis AG API Contract Manufacturing Product Portfolio
  18. 8.3.5 Novartis AG Recent Developments
  19. 8.4 Merck＆Co.，Inc
  20. 8.4.1 Merck＆Co.，Inc Company Information
  21. 8.4.2 Merck＆Co.，Inc Business Overview
  22. 8.4.3 Merck＆Co.，Inc API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck＆Co.，Inc API Contract Manufacturing Product Portfolio
  24. 8.4.5 Merck＆Co.，Inc Recent Developments
  25. 8.5 GlaxoSmithKline Pharmaceuticals Ltd
  26. 8.5.1 GlaxoSmithKline Pharmaceuticals Ltd Company Information
  27. 8.5.2 GlaxoSmithKline Pharmaceuticals Ltd Business Overview
  28. 8.5.3 GlaxoSmithKline Pharmaceuticals Ltd API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Pharmaceuticals Ltd API Contract Manufacturing Product Portfolio
  30. 8.5.5 GlaxoSmithKline Pharmaceuticals Ltd Recent Developments
  31. 8.6 AstraZeneca Plc
  32. 8.6.1 AstraZeneca Plc Company Information
  33. 8.6.2 AstraZeneca Plc Business Overview
  34. 8.6.3 AstraZeneca Plc API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Plc API Contract Manufacturing Product Portfolio
  36. 8.6.5 AstraZeneca Plc Recent Developments
  37. 8.7 Sandoz-Lek-Biochemie
  38. 8.7.1 Sandoz-Lek-Biochemie Company Information
  39. 8.7.2 Sandoz-Lek-Biochemie Business Overview
  40. 8.7.3 Sandoz-Lek-Biochemie API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sandoz-Lek-Biochemie API Contract Manufacturing Product Portfolio
  42. 8.7.5 Sandoz-Lek-Biochemie Recent Developments
  43. 8.8 Reddy's Laboratories Ltd
  44. 8.8.1 Reddy's Laboratories Ltd Company Information
  45. 8.8.2 Reddy's Laboratories Ltd Business Overview
  46. 8.8.3 Reddy's Laboratories Ltd API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Reddy's Laboratories Ltd API Contract Manufacturing Product Portfolio
  48. 8.8.5 Reddy's Laboratories Ltd Recent Developments
  49. 8.9 Ranbaxy Laboratories Ltd.
  50. 8.9.1 Ranbaxy Laboratories Ltd. Company Information
  51. 8.9.2 Ranbaxy Laboratories Ltd. Business Overview
  52. 8.9.3 Ranbaxy Laboratories Ltd. API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ranbaxy Laboratories Ltd. API Contract Manufacturing Product Portfolio
  54. 8.9.5 Ranbaxy Laboratories Ltd. Recent Developments
  55. 8.10 Piramal Pharma Solutions
  56. 8.10.1 Piramal Pharma Solutions Company Information
  57. 8.10.2 Piramal Pharma Solutions Business Overview
  58. 8.10.3 Piramal Pharma Solutions API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Piramal Pharma Solutions API Contract Manufacturing Product Portfolio
  60. 8.10.5 Piramal Pharma Solutions Recent Developments
  61. 8.11 BoehringerIngelhein GmbH
  62. 8.11.1 BoehringerIngelhein GmbH Company Information
  63. 8.11.2 BoehringerIngelhein GmbH Business Overview
  64. 8.11.3 BoehringerIngelhein GmbH API Contract Manufacturing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 BoehringerIngelhein GmbH API Contract Manufacturing Product Portfolio
  66. 8.11.5 BoehringerIngelhein GmbH Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst